share_log

With 51% Ownership, Insiders at China Medical System Holdings Limited (HKG:867) Are Pretty Optimistic and Have Been Buying Recently

With 51% Ownership, Insiders at China Medical System Holdings Limited (HKG:867) Are Pretty Optimistic and Have Been Buying Recently

在中國醫療系統控股有限公司(HKG:867),持股比例達51%的內部人士非常樂觀,並最近一直在購買。
Simply Wall St ·  06/21 02:57

Key Insights

主要見解

  • Insiders appear to have a vested interest in China Medical System Holdings' growth, as seen by their sizeable ownership
  • A total of 2 investors have a majority stake in the company with 50% ownership
  • Recent purchases by insiders
  • 從中看出,內部人士對於中國醫藥系統控股有着很大的持股興趣。
  • 共有2位投資者擁有該公司50%的所有權。
  • 最近有內部人員購買。

Every investor in China Medical System Holdings Limited (HKG:867) should be aware of the most powerful shareholder groups. With 51% stake, individual insiders possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

中國醫療保健股份有限公司(HKG:867)的每一位投資者都應該了解最強大的股東群體。個人內部持有51%的股權,擁有公司的最大股份。換句話說,該群體面臨最大的上行潛力(或下行風險)。

Notably, insiders have bought shares recently. This could signal that stock prices could go up and insiders are here for it.

內部人士最近購買了股票,這可能意味着股價可能會上漲而內部人士也可以從中受益。

Let's delve deeper into each type of owner of China Medical System Holdings, beginning with the chart below.

讓我們深入了解每種擁有者類型的中國醫藥系統控股,從下面的圖表開始。

ownership-breakdown
SEHK:867 Ownership Breakdown June 21st 2024
SEHK:867股權分佈2024年6月21日

What Does The Institutional Ownership Tell Us About China Medical System Holdings?

關於中國醫藥系統控股的機構投資者持股,我們還可以看出,機構投資者在該公司持有相當數量的股份。這意味着爲這些機構投資的分析師已經研究了該股並且看好它。但就像其他任何人一樣,他們也可能犯錯誤。當多個機構擁有一支股票時,總會存在他們湧入'衆籌式交易'的風險。這種風險在一個沒有增長曆史的公司中更高。您可以在下面看到中國醫藥系統控股的歷史收益和營業收入,但請記住,故事總是有更多的內容。

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

As you can see, institutional investors have a fair amount of stake in China Medical System Holdings. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see China Medical System Holdings' historic earnings and revenue below, but keep in mind there's always more to the story.

我們尤其需要考慮持有公司的不同群體,但更重要的是考慮其他因素。例如,我們已經發現了中國醫藥系統控股2個警示信號,您應該注意到這些信號。

earnings-and-revenue-growth
SEHK:867 Earnings and Revenue Growth June 21st 2024
SEHK:867收入和營業收入增長2024年6月21日

China Medical System Holdings is not owned by hedge funds. The company's CEO Kong Lam is the largest shareholder with 47% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 2.9% and 2.1%, of the shares outstanding, respectively. Interestingly, the second-largest shareholder, Hongbing Chen is also Chief Operating Officer, again, pointing towards strong insider ownership amongst the company's top shareholders.

中國醫藥系統控股不是對沖基金持有的公司。公司CEO孔藍擁有47%的流通股份,同時,第二大和第三大股東分別擁有流通股份的2.9%和2.1%。有趣的是,第二大股東陳紅冰也是首席運營官,再次表明公司內部人士在公司的最大股東中佔有很高的比例。

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

爲了使我們的研究更有趣,我們發現前2名股東擁有該公司的大部分所有權,這意味着他們足夠強大,可以影響公司的決策。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然仔細研究公司的機構持股數據是有意義的,但研究分析師對該股票的看法也是有意義的。有相當數量的分析師在跟蹤該股票,因此了解他們對於未來發展的總體看法可能會有所幫助。

Insider Ownership Of China Medical System Holdings

中國醫藥系統控股的內部人士擁有公司的大部分股份。這意味着他們可以共同爲公司做出決策。這意味着內部人員持有逾86億港元的股份,並與股東的利益高度一致。您可以在此處查看他們是否一直減持股份。

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間是不同的。我們的數據反映了個別內部人員,至少捕捉到了董事會成員。公司管理業務,但首席執行官即使是董事會成員也必須向董事會負責。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

Our most recent data indicates that insiders own the majority of China Medical System Holdings Limited. This means they can collectively make decisions for the company. That means insiders have a very meaningful HK$8.6b stake in this HK$17b business. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if they have been selling down their stake.

普通公衆(包括散戶投資者)擁有該公司29%的股份,因此他們不容易被忽視。雖然這個擁股比例相當大,但如果決定不與其他大股東保持同步,則可能無法改變公司政策。

General Public Ownership

一般大衆所有權

The general public-- including retail investors -- own 29% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

儘管考慮不同擁有公司的團體是值得的,但有些因素更爲重要。例如,我們已經爲中國醫藥系統控股公司確定了2個警示信號,您應該注意到這些信號。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For instance, we've identified 2 warning signs for China Medical System Holdings that you should be aware of.

雖然考慮公司的不同所有者組可能非常有價值,但有其他更重要的因素。例如,我們已經發現了中國醫療保健股份存在2個警告信號,您也應該注意。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論